Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHA:600436)

SHA:600436 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	10,483	10,756	10,036	8,674	8,004	6,493
Other Revenue	32.7	31.87	22.31	19.52	17.29	18.28
Revenue	10,516	10,788	10,058	8,694	8,022	6,511
Revenue Growth (YoY)	-1.39%	7.25%	15.70%	8.38%	23.20%	13.78%
Cost of Revenue	6,271	6,189	5,363	4,735	3,968	3,584
Gross Profit	4,245	4,599	4,695	3,959	4,054	2,926
Selling, General & Admin	842.53	858.09	1,150	814.41	1,027	982.2
Research & Development	273.82	269.59	232.35	230.03	199.51	97.55
Other Operating Expenses	53.98	48.19	70.77	71.96	72.05	53.23
Operating Expenses	1,183	1,179	1,465	1,110	1,306	1,135
Operating Income	3,062	3,420	3,230	2,849	2,748	1,792
Interest Expense	-34.33	-37.62	-37.31	-38.01	-32.9	-27.39
Interest & Investment Income	175.13	182.59	170.81	171.62	144.48	149.27
Currency Exchange Gain (Loss)	1.62	7.57	3.09	7.18	-3.28	-3.27
Other Non Operating Income (Expenses)	-0.37	-3.03	6.02	-36.47	-21.62	-4.4
EBT Excluding Unusual Items	3,204	3,569	3,373	2,954	2,834	1,906
Gain (Loss) on Sale of Investments	-1.48	-8.95	8.32	-0.02	4.54	6.72
Gain (Loss) on Sale of Assets	5.32	3.87	0.96	11.14	27.59	40.29
Asset Writedown	-	-	-	-0.33	-1.02	-
Other Unusual Items	-25.77	-25.54	-13.06	13.18	3.55	26.08
Pretax Income	3,182	3,539	3,369	2,978	2,869	1,979
Income Tax Expense	487.08	543.21	517.77	454.76	404.23	289.54
Earnings From Continuing Operations	2,695	2,996	2,851	2,523	2,465	1,689
Minority Interest in Earnings	2.6	-18.52	-53.79	-50.63	-32.9	-17.84
Net Income	2,698	2,977	2,797	2,472	2,432	1,672
Net Income to Common	2,698	2,977	2,797	2,472	2,432	1,672
Net Income Growth	-9.41%	6.42%	13.15%	1.66%	45.49%	21.62%
Shares Outstanding (Basic)	604	604	603	603	603	603
Shares Outstanding (Diluted)	604	604	603	603	603	603
Shares Change (YoY)	0.13%	0.16%	-0.02%	-0.07%	0.00%	0.11%
EPS (Basic)	4.47	4.93	4.64	4.10	4.03	2.77
EPS (Diluted)	4.47	4.93	4.64	4.10	4.03	2.77
EPS Growth	-9.53%	6.25%	13.17%	1.74%	45.49%	21.49%
Free Cash Flow	124.85	245.41	2,065	6,698	370.11	1,048
Free Cash Flow Per Share	0.21	0.41	3.42	11.11	0.61	1.74
Dividend Per Share	3.220	2.970	2.320	1.250	1.210	0.900
Dividend Growth	-7.21%	28.02%	85.60%	3.31%	34.44%	9.76%
Gross Margin	40.37%	42.63%	46.68%	45.54%	50.53%	44.95%
Operating Margin	29.12%	31.70%	32.11%	32.77%	34.25%	27.52%
Profit Margin	25.65%	27.60%	27.81%	28.44%	30.32%	25.67%
Free Cash Flow Margin	1.19%	2.27%	20.53%	77.04%	4.61%	16.10%
EBITDA	3,128	3,475	3,298	2,897	2,854	1,882
EBITDA Margin	29.74%	32.21%	32.79%	33.32%	35.58%	28.90%
D&A For EBITDA	65.58	55	67.82	47.36	106.25	90.21
EBIT	3,062	3,420	3,230	2,849	2,748	1,792
EBIT Margin	29.12%	31.70%	32.11%	32.77%	34.25%	27.52%
Effective Tax Rate	15.31%	15.35%	15.37%	15.27%	14.09%	14.63%
Revenue as Reported	10,516	10,788	10,058	8,694	8,022	6,511
Advertising Expenses	-	258.62	531.48	255.04	445	473.79

Source: S&P Global Market Intelligence. Standard template. Financial Sources.